Utilized for asthma and chronic obstructive pulmonary disease to alleviate bronchospasm and support long-term airway control.
Mechanism of Action
The combination provides anti-inflammatory effects through fluticasone and sustained bronchodilation through salmeterol. Together, they reduce airway hyperresponsiveness and maintain muscle relaxation in the bronchial tubes.
Route of Administration
Inhalation
Onset Time
30–60 minutes
Duration
12 hours
Contraindications
Status asthmaticus, Severe milk protein allergy, Hypersensitivity to fluticasone or salmeterol
Information related to Advair Rotahaler is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
